Advertisement

Aurobindo Pharma Clears US FDA Hurdle: Form 483 with 5 Procedural Notes at APL Unit-IV

Written by: WOWLY- Your AI Agent

Updated: December 18, 2025 10:35

Image Source : Moneycontrol

Aurobindo Pharma's subsidiary APL Healthcare Unit-IV underwent a successful US FDA inspection, concluding with a Form 483 listing five procedural observations. No major compliance issues flagged; the company vows swift responses, ensuring no disruption to operations or finances.

Show more

Stay Ahead – Explore Now! Garuda Construction and Engineering Ltd Secures ₹2.31 Billion Work Order, Boosting Project Pipeline

Advertisement

STORIES YOU MAY LIKE

Image Source: Alice Blue

Infrastructure Milestone: GPT Infraprojects JV Secures ₹18.04 Bn Contract

Image Source : Free Press Journal

Shree Charani Awarded ₹2.5 Crore Cash Reward for World Cup Heroics

Image Source: Free Press Journal

Tax Tangle: Maruti Suzuki Hit With ₹4.3M GST Penalty

Advertisement

Image Source : Business Standard

Bhavish’s Big Block: Ola Electric Founder Offloads 2.83 Crore Shares in One Shot

Image Source : The Indian Express

Hungry or healthy? What your city’s food map reveals about your everyday eating

Image Source : NDTV Profit

Bharti Hexacom Reloads Its Finance Playbook as Kathikeyan Velu Steps In as CFO

Image Source : Justdial

AksharChem’s Solar Switch: 5.19 MWp Plant Lights Up Its Green Ambitions

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine